Work

A review of exploration of RNA interference of BCL11A gene approach for induction of fetal hemoglobin in transgenic sickle cell mouse model

Year: 2020
Type: review
Abstract: Sickle-cell Disease (SCD) is a neglected chronic disorder of increasing global health importance. Worldwide estimation of about 20-25 million sickle cell disease individuals and out of which 5-10 million are living in India1. Still now, there is no complete treatment for SCD. Hematopoietic stem cell transplantation (HSCT) which is only hopeful treatment for SCD but this area is in beginning stag. Blood transfusion temporary treatment but has limitations, as most patients do not get a matched donor and unrelated donors have higher risks of complications, owing to immune reactions between the donor and the recipient. In this review we detail described about BCL11A silencing and how it will increases the fetal hemoglobin that is now emerging therapy for Sickle Cell Disease.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W3088444278
FWCI:
Cites:
Cited by:
Related to: 10